FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2062396317> ?p ?o ?g. }

• W2062396317 abstract "To distinguish which children with precocious puberty (PP) and early puberty (EP) should be treated and which followed without therapy. To determine the effect of GnRH analog treatment on the final height of treated patients and compare the effect of two different analogs on gonadotropin suppression and final height.Sixteen females with PP or EP with a mean chronological age (CA) of 8.8 +/- 1.4 years and a mean bone age (BA) of 10.8 +/- 1.3 years were treated for a mean of 2.7 +/- 1.0 years with a GnRH analog (triptorelin or leuprolide acetate; group A), while 21 girls with a mean CA of 8.5 +/- 1.0 years, a mean BA of 9.7 +/- 1.4 years and a predicted adult height of >155 cm were followed without therapy (group B). Criteria for treatment were one of: a. predicted adult height (PAH) of <155 cm initially or at any time during follow up; b. PAH over 155 cm with a dramatic decrease in PAH over a 6-month follow-up period; c. advanced and rapidly progressing breast development for age (Tanner 3 before the age of 9 years).GnRHa therapy suppressed gonadotropins in group A, while gonadotropins increased gradually in group B. Height velocity (HV) decreased in group A, while it remained accelerated in group B; BA increased a mean of 1.7 +/- 0.5 years in group A and 3.2 +/- 0.3 years in group B. This resulted in a height increase in group A from a baseline PAH of 153.7 +/- 1.2 cm to a final height (FH) of 160.9 +/- 4.0 cm (p <0.001), clearly above their target height (TH) of 157.7 +/- 4.2 cm. The height of group B children did not change over time (164.1 +/- 4.1 cm before therapy and 166.0 +/- 6.0 cm at FH), both above their TH. The mean leuprolide acetate dose utilized in this study decreased during treatment, while both the initial and final triptorelin dose remained unchanged. Adequate gonadotropin suppression (peak level of LH and FSH of <2 IU/l after i.v. GnRH stimulation) was noted with both leuprolide acetate and triptorelin, although LH suppression was slightly more pronounced with triptorelin. BA advanced 1.8 +/- 0.4 years during leuprolide acetate treatment and 1.5 +/- 0.3 years with triptorelin, so that FH increased a mean of 5.5 +/- 1.3 cm with leuprolide acetate and 8.7 +/- 2.2 cm with triptorelin.PAH of <155 cm before or during therapy, PAH of >155 cm with a dramatic decrease in predicted height over a 6-month follow-up period and/or advanced and rapidly progressing breast development in girls with PP or EP were useful parameters in deciding which patients to treat. GnRHa therapy suppressed gonadotropins, HV and bone maturation in children with an accelerated form of PP or EP, resulting in a significant height increase. Final height remained stable over time in untreated patients. Adequate gonadotropin suppression was noted with both analogs, although with the doses of analog used in our study, LH and BA suppression were more pronounced with triptorelin, resulting in a larger height gain." @default.
• W2062396317 created "2016-06-24" @default.
• W2062396317 creator A5009073681 @default.
• W2062396317 creator A5015248834 @default.
• W2062396317 creator A5063025865 @default.
• W2062396317 date "2004-01-01" @default.
• W2062396317 modified "2023-10-14" @default.
• W2062396317 title "Accelerated Versus Slowly Progressive Forms of Puberty in Girls with Precocious and Early Puberty. Gonadotropin Suppressive Effect and Final Height Obtained with Two Different Analogs" @default.
• W2062396317 cites W1965329413 @default.
• W2062396317 cites W1968494990 @default.
• W2062396317 cites W1990539816 @default.
• W2062396317 cites W1997068376 @default.
• W2062396317 cites W2010884914 @default.
• W2062396317 cites W2014106566 @default.
• W2062396317 cites W2042572152 @default.
• W2062396317 cites W2048370865 @default.
• W2062396317 cites W2076243488 @default.
• W2062396317 cites W2083388085 @default.
• W2062396317 cites W2092419142 @default.
• W2062396317 cites W2157751000 @default.
• W2062396317 cites W2163225705 @default.
• W2062396317 cites W4235128481 @default.
• W2062396317 cites W4238175250 @default.
• W2062396317 cites W4244491069 @default.
• W2062396317 cites W4249942437 @default.
• W2062396317 cites W4252217297 @default.
• W2062396317 doi "https://doi.org/10.1515/jpem.2004.17.5.759" @default.
• W2062396317 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15237711" @default.
• W2062396317 hasPublicationYear "2004" @default.
• W2062396317 type Work @default.
• W2062396317 sameAs 2062396317 @default.
• W2062396317 citedByCount "25" @default.
• W2062396317 countsByYear W20623963172012 @default.
• W2062396317 countsByYear W20623963172013 @default.
• W2062396317 countsByYear W20623963172016 @default.
• W2062396317 countsByYear W20623963172017 @default.
• W2062396317 countsByYear W20623963172018 @default.
• W2062396317 countsByYear W20623963172019 @default.
• W2062396317 countsByYear W20623963172020 @default.
• W2062396317 countsByYear W20623963172021 @default.
• W2062396317 countsByYear W20623963172023 @default.
• W2062396317 crossrefType "journal-article" @default.
• W2062396317 hasAuthorship W2062396317A5009073681 @default.
• W2062396317 hasAuthorship W2062396317A5015248834 @default.
• W2062396317 hasAuthorship W2062396317A5063025865 @default.
• W2062396317 hasConcept C126322002 @default.
• W2062396317 hasConcept C134018914 @default.
• W2062396317 hasConcept C2776880931 @default.
• W2062396317 hasConcept C2777785397 @default.
• W2062396317 hasConcept C2778367240 @default.
• W2062396317 hasConcept C2778575703 @default.
• W2062396317 hasConcept C2778782382 @default.
• W2062396317 hasConcept C2778894405 @default.
• W2062396317 hasConcept C2779448150 @default.
• W2062396317 hasConcept C2780678043 @default.
• W2062396317 hasConcept C2908531242 @default.
• W2062396317 hasConcept C71315377 @default.
• W2062396317 hasConcept C71924100 @default.
• W2062396317 hasConcept C89551170 @default.
• W2062396317 hasConceptScore W2062396317C126322002 @default.
• W2062396317 hasConceptScore W2062396317C134018914 @default.
• W2062396317 hasConceptScore W2062396317C2776880931 @default.
• W2062396317 hasConceptScore W2062396317C2777785397 @default.
• W2062396317 hasConceptScore W2062396317C2778367240 @default.
• W2062396317 hasConceptScore W2062396317C2778575703 @default.
• W2062396317 hasConceptScore W2062396317C2778782382 @default.
• W2062396317 hasConceptScore W2062396317C2778894405 @default.
• W2062396317 hasConceptScore W2062396317C2779448150 @default.
• W2062396317 hasConceptScore W2062396317C2780678043 @default.
• W2062396317 hasConceptScore W2062396317C2908531242 @default.
• W2062396317 hasConceptScore W2062396317C71315377 @default.
• W2062396317 hasConceptScore W2062396317C71924100 @default.
• W2062396317 hasConceptScore W2062396317C89551170 @default.
• W2062396317 hasIssue "5" @default.
• W2062396317 hasLocation W20623963171 @default.
• W2062396317 hasLocation W20623963172 @default.
• W2062396317 hasOpenAccess W2062396317 @default.
• W2062396317 hasPrimaryLocation W20623963171 @default.
• W2062396317 hasRelatedWork W177474959 @default.
• W2062396317 hasRelatedWork W2007397639 @default.
• W2062396317 hasRelatedWork W2057261421 @default.
• W2062396317 hasRelatedWork W2057661271 @default.
• W2062396317 hasRelatedWork W2077249667 @default.
• W2062396317 hasRelatedWork W2129018919 @default.
• W2062396317 hasRelatedWork W2150017471 @default.
• W2062396317 hasRelatedWork W2391161199 @default.
• W2062396317 hasRelatedWork W2409392006 @default.
• W2062396317 hasRelatedWork W2766136622 @default.
• W2062396317 hasVolume "17" @default.
• W2062396317 isParatext "false" @default.
• W2062396317 isRetracted "false" @default.
• W2062396317 magId "2062396317" @default.
• W2062396317 workType "article" @default.